200 related articles for article (PubMed ID: 3124829)
1. Treatment of streptozotocin-diabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi.
Gawler D; Milligan G; Houslay MD
Biochem J; 1988 Jan; 249(2):537-42. PubMed ID: 3124829
[TBL] [Abstract][Full Text] [Related]
2. Metformin treatment of lean and obese Zucker rats modulates the ability of glucagon and insulin to regulate hepatocyte adenylate cyclase activity.
Gawler DJ; Wilson A; Houslay MD
J Endocrinol; 1989 Jul; 122(1):207-12. PubMed ID: 2671238
[TBL] [Abstract][Full Text] [Related]
3. Glucagon desensitization of adenylate cyclase and stimulation of inositol phospholipid metabolism does not involve the inhibitory guanine nucleotide regulatory protein Gi, which is inactivated upon challenge of hepatocytes with glucagon.
Murphy GJ; Gawler DJ; Milligan G; Wakelam MJ; Pyne NJ; Houslay MD
Biochem J; 1989 Apr; 259(1):191-7. PubMed ID: 2497730
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes.
Bushfield M; Griffiths SL; Murphy GJ; Pyne NJ; Knowler JT; Milligan G; Parker PJ; Mollner S; Houslay MD
Biochem J; 1990 Oct; 271(2):365-72. PubMed ID: 1700700
[TBL] [Abstract][Full Text] [Related]
5. Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase.
Heyworth CM; Houslay MD
Biochem J; 1983 Aug; 214(2):547-52. PubMed ID: 6311187
[TBL] [Abstract][Full Text] [Related]
6. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
Soman V; Felig P
J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
[TBL] [Abstract][Full Text] [Related]
7. Guanine nucleotide binding regulatory proteins and adenylate cyclase in livers of streptozotocin- and BB/Wor-diabetic rats. Immunodetection of Gs and Gi with antisera prepared against synthetic peptides.
Lynch CJ; Blackmore PF; Johnson EH; Wange RL; Krone PK; Exton JH
J Clin Invest; 1989 Jun; 83(6):2050-62. PubMed ID: 2498395
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of inhibitory guanine nucleotide regulatory protein (Gi) function in liver and hepatocyte membranes from streptozotocin-treated rats.
Kirkham DM; Murphy GJ; Young P
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):301-4. PubMed ID: 1534652
[TBL] [Abstract][Full Text] [Related]
9. Diabetes abolishes the GTP-dependent, but not the receptor-dependent inhibitory function of the inhibitory guanine-nucleotide-binding regulatory protein (Gi) on adipocyte adenylate cyclase activity.
Strassheim D; Milligan G; Houslay MD
Biochem J; 1990 Mar; 266(2):521-6. PubMed ID: 2156498
[TBL] [Abstract][Full Text] [Related]
10. The action of islet activating protein (pertussis toxin) on insulin's ability to inhibit adenylate cyclase and activate cyclic AMP phosphodiesterases in hepatocytes.
Heyworth CM; Grey AM; Wilson SR; Hanski E; Houslay MD
Biochem J; 1986 Apr; 235(1):145-9. PubMed ID: 3017298
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
[TBL] [Abstract][Full Text] [Related]
12. Acidic phospholipid species inhibit adenylate cyclase activity in rat liver plasma membranes.
Houslay MD; Needham L; Dodd NJ; Grey AM
Biochem J; 1986 Apr; 235(1):237-43. PubMed ID: 3741383
[TBL] [Abstract][Full Text] [Related]
13. Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein.
Allgayer H; Bachmann W; Hepp KD
Diabetologia; 1982 Jun; 22(6):464-7. PubMed ID: 6286396
[TBL] [Abstract][Full Text] [Related]
14. The function but not the expression of rat liver inhibitory guanine nucleotide binding protein is altered in streptozotocin-induced diabetes.
Allard WJ; Vicario PP; Saperstein R; Slater EE; Strout HV
Endocrinology; 1991 Jul; 129(1):169-75. PubMed ID: 1905225
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intact hepatocytes with either the phorbol ester TPA or glucagon elicits the phosphorylation and functional inactivation of the inhibitory guanine nucleotide regulatory protein Gi.
Pyne NJ; Murphy GJ; Milligan G; Houslay MD
FEBS Lett; 1989 Jan; 243(1):77-82. PubMed ID: 2493392
[TBL] [Abstract][Full Text] [Related]
16. Insulin and glucagon attenuate the ability of cholera toxin to activate adenylate cyclase in intact hepatocytes.
Irvine FJ; Houslay MD
Biochem J; 1988 Apr; 251(2):447-52. PubMed ID: 2840894
[TBL] [Abstract][Full Text] [Related]
17. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
Wallace AV; Heyworth CM; Houslay MD
Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin-induced diabetes and hormone sensitivity of adenylate cyclase in rat myocardial sarcolemma, aorta and liver.
Srivastava AK; Anand-Srivastava MB
Biochem Pharmacol; 1985 Jun; 34(11):2013-7. PubMed ID: 4039939
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-induced changes in the Gi-modulated muscarinic receptor-adenylyl cyclase system in rat myocardium.
Fu LX; Bergh CH; Liang QM; Sjögren KG; Xu X; Eriksson P; Hoebeke J; Hjalmarson A
Pharmacol Toxicol; 1994; 75(3-4):186-93. PubMed ID: 7800662
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholines can modulate the activity of the glucagon-stimulated adenylate cyclase from rat liver plasma membranes.
Houslay MD; Palmer RW
Biochem J; 1979 Jan; 178(1):217-21. PubMed ID: 435279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
